公司資料
Vaccinex 股價、新聞與催化劑
- 股票代碼:
- VCNX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.78 USD (-6.83%)
收盤價
最後更新: 2026年8月17日
—
市值
股價為何變動
Current closing-price context is not available for VCNX.
公司概覽
業務概覽
Vaccinex is a biotechnology company focused on antibody therapies and immunology, with a history of pursuing difficult oncology and neurodegenerative targets. Its story is tied to platform science and the challenge of turning it into durable value.
所在地與產業分類
Vaccinex is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology with a therapeutic platform focus.
商業模式特徵
The business model depends on clinical validation, strategic partnerships, and capital management. Investors typically track early data, platform breadth, and whether the company can progress a narrow pipeline without dilution pressure.
生技產業定位
Vaccinex sits in a high-risk platform-biotech niche. It remains catalyst-sensitive because the company's value depends on a limited number of programs and the market's belief in its science.
未來催化劑
- Vaccinex is still a broad antibody-platform story, with Alzheimer’s, Huntington’s disease, and cancer all sitting inside the same frame. That breadth is useful, but the company now needs one of those programs to move from scientific promise to something more concrete.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。